Sari la conținut

Equillium Inc.: Diferență între versiuni

1.176 de octeți adăugați ,  18 septembrie
Pagină nouă: Pagina dedicata companiei Equillium Inc. listata cu simbolul US.EQ ==Descriere companie== Equillium, Inc. (www.quilliumbio.com) is a clinical-stage biotechnology company. The Company develops products to treat severe autoimmune and inflammatory disorders with high unmet medical needs. The Company's initial product candidate, itolizumab (EQ001), is a clinical-stage, a first-in-class monoclonal antibody that selectively targets CD6, a co-stimulatory receptor differentially exp...
(Pagină nouă: Pagina dedicata companiei Equillium Inc. listata cu simbolul US.EQ ==Descriere companie== Equillium, Inc. (www.quilliumbio.com) is a clinical-stage biotechnology company. The Company develops products to treat severe autoimmune and inflammatory disorders with high unmet medical needs. The Company's initial product candidate, itolizumab (EQ001), is a clinical-stage, a first-in-class monoclonal antibody that selectively targets CD6, a co-stimulatory receptor differentially exp...)
(Nicio diferență)